Exact Mass: 306.0506

Exact Mass Matches: 306.0506

Found 71 metabolites which its exact mass value is equals to given mass value 306.0506, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Isoprothiolane sulfoxide

Propanedioic acid, 1,3-dithiolan-2-ylidene-, bis(1-methylethyl) ester, 5-oxide

C12H18O5S2 (306.0596)


   

Kinobscurinone

Kinobscurinone; 4,9-Dihydroxy-2-methyl-11H-benzo[b]fluorene-5,10,11-trione

C18H10O5 (306.0528)


An organic heterotetracyclic compound that is 10,11-dihydro-5H-benzo[b]fluorene substituted by a methyl group at position 1, hydroxy groups at positions 4 and 9, and oxo groups at positions 5, 10 and 11.

   

Phenyl 5-phospho-alpha-D-ribofuranoside

phenyl 5-phosphono-alpha-D-ribofuranoside

C11H15O8P (306.0505)


   

4-(beta-D-Ribofuranosyl)phenol 5-phosphate

4-(beta-D-Ribofuranosyl)phenol 5-phosphate

C11H15O8P (306.0505)


   

Vadadustat

Vadadustat

C14H11ClN2O4 (306.0407)


COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials B - Blood and blood forming organs > B03 - Antianemic preparations C78275 - Agent Affecting Blood or Body Fluid C471 - Enzyme Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Vadadustat (PG-1016548) is a titratable, oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor[1]. Vadadustat is an erythropoiesis-stimulating agent and has the potential for anemia treatment in chronic kidney disease in vivo[1][2].

   

N-(4-Carboxy-4-Oxobutanoyl)-L-Cysteinylglycine

N-(4-Carboxy-4-Oxobutanoyl)-L-Cysteinylglycine

C10H14N2O7S (306.0522)


   

4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphate

4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphuric acid

C11H14O8S (306.0409)


4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphate belongs to the family of Hydroxy Fatty Acids. These are fatty acids in which the chain bears an hydroxyl group.

   

4-hydroxy-5-[4-hydroxy-3-(sulfooxy)phenyl]pentanoic acid

4-Hydroxy-5-[4-hydroxy-3-(sulphooxy)phenyl]pentanoic acid

C11H14O8S (306.0409)


4-hydroxy-5-[4-hydroxy-3-(sulfooxy)phenyl]pentanoic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 5-(3,4-dihydroxyphenyl)-4-hydroxypentanoic acid. It is generated by Sulfotransferase 1A3 (P0DMM9) and Sulfotransferase enzymes via a -3-O-sulfation-of-phenolic-compound reaction. This -3-O-sulfation-of-phenolic-compound occurs in humans.

   

4-Hydroxy-5-(3',4'-dihydroxyphenyl)-valeric acid 4'-sulfate

4-Hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid 4-sulphuric acid

C11H14O8S (306.0409)


   

4-Hydroxy-5-(3',5'-dihydroxyphenyl)-valeric acid sulfate

4-Hydroxy-5-(3,5-dihydroxyphenyl)-valeric acid sulphuric acid

C11H14O8S (306.0409)


   

Calycin

3-(3-hydroxy-5-oxo-4-phenyl-2,5-dihydrofuran-2-ylidene)-2,3-dihydro-1-benzofuran-2-one

C18H10O5 (306.0528)


   

Dictyostelium

1-((3,5-Dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone

C13H16Cl2O4 (306.0426)


   

Songaglabrene

2-[3,4-(Methylenedioxy)phenyl]-4H-furo[2,3-h]-1-benzopyran-4-one

C18H10O5 (306.0528)


   

3,4-Methylenedioxyfurano[2,3:6,7]aurone

3,4-Methylenedioxyfurano [ 2",3":6,7 ] aurone

C18H10O5 (306.0528)


   

Fluostatin A

Fluostatin A

C18H10O5 (306.0528)


   

2-(3,4-Dihydroxyphenyl)naphthalic anhydride

2-(3,4-Dihydroxyphenyl)naphthalic anhydride

C18H10O5 (306.0528)


   

Neoduleen

6H- [ 1,3 ] Dioxolo [ 5,6 ] benzofuro [ 3,2-c ] furo [ 3,2-g ] [ 1 ] benzopyran

C18H10O5 (306.0528)


   
   
   

3,5-Dihydroxy-1H,3H-2-benzopyrano[6,5,4-mna]xanthene-1-one

3,5-Dihydroxy-1H,3H-2-benzopyrano[6,5,4-mna]xanthene-1-one

C18H10O5 (306.0528)


   

3,4-dihydroxy-5-phenyl-naphthalene-1,8-dicarboxylic acid anhydride|3,4-Dihydroxy-5-phenylnaphthalsaeureanhydrid|5,6-Dihydroxy-7-phenyl-1H,3H-naphtho[1,8-cd]pyran-1,3-dione|5,6-dihydroxy-7-phenyl-3H-benzo[de]isochromene-1,3-dione

3,4-dihydroxy-5-phenyl-naphthalene-1,8-dicarboxylic acid anhydride|3,4-Dihydroxy-5-phenylnaphthalsaeureanhydrid|5,6-Dihydroxy-7-phenyl-1H,3H-naphtho[1,8-cd]pyran-1,3-dione|5,6-dihydroxy-7-phenyl-3H-benzo[de]isochromene-1,3-dione

C18H10O5 (306.0528)


   

isoganxinonic acid A

isoganxinonic acid A

C18H10O5 (306.0528)


   
   

6-Deoxy,6beta-chloro-Cyathiformine B|cyathiformine C|cyathioformine C

6-Deoxy,6beta-chloro-Cyathiformine B|cyathiformine C|cyathioformine C

C12H15ClO7 (306.0506)


   

calycin|calycine

calycin|calycine

C18H10O5 (306.0528)


   

5-((E)-2-Oxo-benzofuran-3-yliden)-3-phenyl-furan-2,4-dion|5-((E)-2-oxo-benzofuran-3-ylidene)-3-phenyl-furan-2,4-dione

5-((E)-2-Oxo-benzofuran-3-yliden)-3-phenyl-furan-2,4-dion|5-((E)-2-oxo-benzofuran-3-ylidene)-3-phenyl-furan-2,4-dione

C18H10O5 (306.0528)


   

7-Hydroxy-[3,4]bichromenyl-2,2-dione

"NCGC00160336-01!7-Hydroxy-[3,4]bichromenyl-2,2-dione"

C18H10O5 (306.0528)


   
   

1H-Pyrrole-2,5-dione,1-[4-(dimethylamino)-3,5-dinitrophenyl]-

1H-Pyrrole-2,5-dione,1-[4-(dimethylamino)-3,5-dinitrophenyl]-

C12H10N4O6 (306.06)


   

7-hydroxy-3-phenyl-2-(trifluoromethyl)chromen-4-one

7-hydroxy-3-phenyl-2-(trifluoromethyl)chromen-4-one

C16H9F3O3 (306.0504)


   

Timefurone

Timefurone

C15H14O5S (306.0562)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent

   

6-(2-Thienyl)-2-[3-(2-thienyl)-2-aziridinyl]-3-oxa-1-azabicyclo[3.1.0]

6-(2-Thienyl)-2-[3-(2-thienyl)-2-aziridinyl]-3-oxa-1-azabicyclo[3.1.0]

C14H14N2O2S2 (306.0497)


   

2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid compound with sulfuric acid (1:1)

2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid compound with sulfuric acid (1:1)

C10H14N2O7S (306.0522)


   

L -Kynurenine sulfate salt

L -Kynurenine sulfate salt

C10H14N2O7S (306.0522)


   

Fascaplysin (chloride)|CDK4 inhibitor

Fascaplysin (chloride)|CDK4 inhibitor

C18H11ClN2O (306.056)


   

Methyl [(4-chloro-3-cyano-7-methoxy-6-quinolinyl)oxy]acetate

Methyl [(4-chloro-3-cyano-7-methoxy-6-quinolinyl)oxy]acetate

C14H11ClN2O4 (306.0407)


   

1,2,11,12-Tetrachlorododecane

1,2,11,12-Tetrachlorododecane

C12H22Cl4 (306.0476)


   

l-kynurenine sulfate

l-kynurenine sulfate

C10H14N2O7S (306.0522)


   

4-BUTYL-4-BROMO-3-FLUOROBIPHENYL

4-BUTYL-4-BROMO-3-FLUOROBIPHENYL

C16H16BrF (306.0419)


   

2-Chloro-1,3-bis(dimethylamino)trimethinium hexafluorophosphate

2-Chloro-1,3-bis(dimethylamino)trimethinium hexafluorophosphate

C7H14ClF6N2P (306.0487)


   

N,N-Dimethyl-10H-phenothiazine-2-sulfonamide

N,N-Dimethyl-10H-phenothiazine-2-sulfonamide

C14H14N2O2S2 (306.0497)


   

5-(3,3-DIMETHYL-UREIDO)-2-ETHOXY-BENZENESULFONYL CHLORIDE

5-(3,3-DIMETHYL-UREIDO)-2-ETHOXY-BENZENESULFONYL CHLORIDE

C11H15ClN2O4S (306.0441)


   

3-Ethyl-5-[3-ethyl-2(3H)-benzothiazolylidene]-2-thioxo-4-oxazolidinone

3-Ethyl-5-[3-ethyl-2(3H)-benzothiazolylidene]-2-thioxo-4-oxazolidinone

C14H14N2O2S2 (306.0497)


   

2-Chloro-1,3-bis(dimentylamino)trimethinium hexafluorophosphate

2-Chloro-1,3-bis(dimentylamino)trimethinium hexafluorophosphate

C7H14ClF6N2P (306.0487)


   

3-[(2-chloro-6-fluorophenyl)methyl]-7,8-dihydro-6H-chromene-2,5-dione

3-[(2-chloro-6-fluorophenyl)methyl]-7,8-dihydro-6H-chromene-2,5-dione

C16H12ClFO3 (306.0459)


   
   
   

1,1,1,3-Tetrachlorododecane

1,1,1,3-Tetrachlorododecane

C12H22Cl4 (306.0476)


   

7-HYDROXY-4-(3-TRIFLUOROMETHYLPHENYL)COUMARIN

7-HYDROXY-4-(3-TRIFLUOROMETHYLPHENYL)COUMARIN

C16H9F3O3 (306.0504)


   

2-Chloro-10H-phenothiazine-10-propanamine 5-oxide

2-Chloro-10H-phenothiazine-10-propanamine 5-oxide

C15H15ClN2OS (306.0594)


   

7-Hydroxy-4-(2-oxochromen-3-yl)chromen-2-one

7-Hydroxy-4-(2-oxochromen-3-yl)chromen-2-one

C18H10O5 (306.0528)


   

3-[(2Z)-3-Hydroxy-4-phenyl-5-oxofuran-2(5H)-ylidene]benzofuran-2(3H)-one

3-[(2Z)-3-Hydroxy-4-phenyl-5-oxofuran-2(5H)-ylidene]benzofuran-2(3H)-one

C18H10O5 (306.0528)


   
   

4-Hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid 4-sulfate

4-Hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid 4-sulfate

C11H14O8S (306.0409)


   

4-(5-O-phospho-beta-D-ribofuranosyl)phenol

4-(5-O-phospho-beta-D-ribofuranosyl)phenol

C11H15O8P (306.0505)


A ribose monophosphate that is D-ribofuranose 5-phosphate in which the anomeric OH group is replaced by a 4-hydroxy phenyl group (the beta-D-anomer).

   

phenyl 5-phosphono-alpha-D-ribofuranoside

phenyl 5-phosphono-alpha-D-ribofuranoside

C11H15O8P (306.0505)


   

1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one

1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one

C13H16Cl2O4 (306.0426)


A differentiation-inducing factor that is hexaphenone bearing two chloro substituents at positions 3 and 5, two hydroxy substituents at positions 2 and 6 as well as a single methoxy substituent at position 4. A secreted, chlorinated molecule that controls cell fate during development of Dictyostelium cells.

   

4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphate

4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphate

C11H14O8S (306.0409)


   

methyl 6-chloro-4,5-dihydroxy-3-[(3-methoxy-3-oxoprop-1-en-2-yl)oxy]cyclohex-1-ene-1-carboxylate

methyl 6-chloro-4,5-dihydroxy-3-[(3-methoxy-3-oxoprop-1-en-2-yl)oxy]cyclohex-1-ene-1-carboxylate

C12H15ClO7 (306.0506)


   

7,8-dihydroxy-10-phenyl-3-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione

7,8-dihydroxy-10-phenyl-3-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione

C18H10O5 (306.0528)


   

methyl (3r,4r,5s,6s)-6-chloro-4,5-dihydroxy-3-[(3-methoxy-3-oxoprop-1-en-2-yl)oxy]cyclohex-1-ene-1-carboxylate

methyl (3r,4r,5s,6s)-6-chloro-4,5-dihydroxy-3-[(3-methoxy-3-oxoprop-1-en-2-yl)oxy]cyclohex-1-ene-1-carboxylate

C12H15ClO7 (306.0506)


   

3-[(2e)-5-hydroxy-3-oxo-4-phenylfuran-2-ylidene]-1-benzofuran-2-one

3-[(2e)-5-hydroxy-3-oxo-4-phenylfuran-2-ylidene]-1-benzofuran-2-one

C18H10O5 (306.0528)


   

3-[(2z)-3-hydroxy-5-oxo-4-phenylfuran-2-ylidene]-1-benzofuran-2-one

3-[(2z)-3-hydroxy-5-oxo-4-phenylfuran-2-ylidene]-1-benzofuran-2-one

C18H10O5 (306.0528)


   

2-(2h-1,3-benzodioxol-5-yl)furo[2,3-h]chromen-4-one

2-(2h-1,3-benzodioxol-5-yl)furo[2,3-h]chromen-4-one

C18H10O5 (306.0528)


   

(13r)-10,13-dihydroxy-8,14-dioxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2,4,6,9,11,16(20),17-octaen-15-one

(13r)-10,13-dihydroxy-8,14-dioxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2,4,6,9,11,16(20),17-octaen-15-one

C18H10O5 (306.0528)


   

5-(2-oxo-1-benzofuran-3-ylidene)-3-phenyloxolane-2,4-dione

5-(2-oxo-1-benzofuran-3-ylidene)-3-phenyloxolane-2,4-dione

C18H10O5 (306.0528)


   

(4e)-4-(2h-1,3-benzodioxol-5-ylmethylidene)-3,10-dioxatricyclo[7.3.0.0²,⁶]dodeca-1,6,8,11-tetraen-5-one

(4e)-4-(2h-1,3-benzodioxol-5-ylmethylidene)-3,10-dioxatricyclo[7.3.0.0²,⁶]dodeca-1,6,8,11-tetraen-5-one

C18H10O5 (306.0528)


   

(3r)-5-[(3e)-2-oxo-1-benzofuran-3-ylidene]-3-phenyloxolane-2,4-dione

(3r)-5-[(3e)-2-oxo-1-benzofuran-3-ylidene]-3-phenyloxolane-2,4-dione

C18H10O5 (306.0528)


   

10,13-dihydroxy-8,14-dioxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2,4,6,9,11,16(20),17-octaen-15-one

10,13-dihydroxy-8,14-dioxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2,4,6,9,11,16(20),17-octaen-15-one

C18H10O5 (306.0528)


   

6,7-dihydroxy-3-methylcyclohexa[a]fluorene-1,4,11-trione

6,7-dihydroxy-3-methylcyclohexa[a]fluorene-1,4,11-trione

C18H10O5 (306.0528)


   

4,12-dihydroxy-5-phenyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),2(7),4,9,11-pentaene-3,6-dione

4,12-dihydroxy-5-phenyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),2(7),4,9,11-pentaene-3,6-dione

C18H10O5 (306.0528)